CS212234B2 - Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways - Google Patents

Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways Download PDF

Info

Publication number
CS212234B2
CS212234B2 CS805266A CS526680A CS212234B2 CS 212234 B2 CS212234 B2 CS 212234B2 CS 805266 A CS805266 A CS 805266A CS 526680 A CS526680 A CS 526680A CS 212234 B2 CS212234 B2 CS 212234B2
Authority
CS
Czechoslovakia
Prior art keywords
nctc
lysate
sodium
water
escherichia coli
Prior art date
Application number
CS805266A
Other languages
Czech (cs)
English (en)
Inventor
Jean-Claude Farine
Anne Rivkine
Isidro Bulto
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of CS212234B2 publication Critical patent/CS212234B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS805266A 1979-07-26 1980-07-25 Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways CS212234B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH692479A CH639852A5 (fr) 1979-07-26 1979-07-26 Medicament contre les maladies infectieuses des voies urinaires et digestives.

Publications (1)

Publication Number Publication Date
CS212234B2 true CS212234B2 (en) 1982-03-26

Family

ID=4317195

Family Applications (1)

Application Number Title Priority Date Filing Date
CS805266A CS212234B2 (en) 1979-07-26 1980-07-25 Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways

Country Status (16)

Country Link
JP (1) JPS5622733A (fr)
AR (1) AR222887A1 (fr)
BE (1) BE884456A (fr)
CH (1) CH639852A5 (fr)
CS (1) CS212234B2 (fr)
DD (1) DD153192A5 (fr)
DE (1) DE3019448A1 (fr)
ES (1) ES491920A0 (fr)
FR (1) FR2462164A1 (fr)
GB (1) GB2054374B (fr)
HU (1) HU181725B (fr)
IT (1) IT1143025B (fr)
PL (1) PL127520B1 (fr)
PT (1) PT71612A (fr)
RO (1) RO80054A (fr)
YU (1) YU42532B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
JP2008529960A (ja) 2003-06-23 2008-08-07 バイオテック トゥールス ソシエテ アノニム エピトープ組成物
MX2009009451A (es) 2007-03-05 2009-10-26 Om Pharma Extracto bacteriano para trastornos del tracto digestivo o uranio y proceso para su preparacion.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336015A (en) * 1970-06-03 1973-11-07 Unilever Ltd Rearing pigs
US3911109A (en) * 1971-10-14 1975-10-07 Lever Brothers Ltd Rearing calves
BE789864A (fr) * 1971-10-14 1973-04-09 Unilever Nv Elevage des veaux
JPS5219927B2 (fr) * 1972-06-08 1977-05-31
GB1462384A (en) * 1973-04-12 1977-01-26 Unilever Ltd Rearing of lambs
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
GB1581776A (en) * 1976-08-18 1980-12-17 Smith Kline Rit Vaccines against oedema disease of piglets

Also Published As

Publication number Publication date
FR2462164B1 (fr) 1983-08-05
JPS5622733A (en) 1981-03-03
BE884456A (fr) 1980-11-17
JPH0255407B2 (fr) 1990-11-27
YU42532B (en) 1988-10-31
FR2462164A1 (fr) 1981-02-13
GB2054374B (en) 1983-06-22
ES8104402A1 (es) 1981-04-01
GB2054374A (en) 1981-02-18
DE3019448C2 (fr) 1987-07-30
PL225853A1 (fr) 1981-05-08
HU181725B (en) 1983-11-28
YU189680A (en) 1983-06-30
IT8049314A0 (it) 1980-07-24
DE3019448A1 (de) 1981-02-12
DD153192A5 (de) 1981-12-30
PT71612A (fr) 1980-08-01
IT1143025B (it) 1986-10-22
AR222887A1 (es) 1981-06-30
RO80054A (fr) 1982-10-26
CH639852A5 (fr) 1983-12-15
PL127520B1 (en) 1983-11-30
ES491920A0 (es) 1981-04-01

Similar Documents

Publication Publication Date Title
EP0199535B1 (fr) Souches bactériennes de Lactobacillus acidophilus et compositions les contenant
CA1246445A (fr) Agent ameliorant la flore intentinale
CN108186784B (zh) 蒲公英复合酵素及其制备方法和用途
CS212234B2 (en) Method of making the immunotherapeutical means against the infection decease uf urine and digesting ways
JP3002552B2 (ja) 皮膚炎治療薬
Ferraz et al. Rothia dentocariosa endocarditis and aortic root abscess
US4223040A (en) Lauric acid for the prevention and treatment of mycobacterial diseases
PL126416B1 (en) Method of obtaining immunobiotherapeutic preparation counteractive against respiratory system diseases
EP1894995B1 (fr) Préparation biologique irilis à base de bactéries du genre bacillus contenant bacillus subtilis et bacillus licheniformis
GB2077101A (en) Antiallergic composition containing streptococci
CN113521262A (zh) 一种具有抗炎效果的溶菌酶制剂
Danø et al. Antibiotic treatment with pivampicillin chloride in respiratory and urinary tract infections
US20070207198A1 (en) Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
Iyengar et al. Plumbago zeylanica L.(Chitrak) a gastrointestinal flora normaliser
SU1722502A1 (ru) Препарат биоспорин дл профилактики и лечени желудочно-кишечных заболеваний человека
JPS6069022A (ja) 免疫調整剤及びその製造法
TW200412989A (en) Gamma delta T cell immunoactivity enhancers containing extract of Lentinus edodes mycelium
EP0904701B1 (fr) Micro-organismes inactivés contenant des minéraux, leur production et utilisation dans des compositions alimentaires, pharmaceutiques ou vétérinaires
RU2123345C1 (ru) Средство для лечения дисбактериоза
RU2101020C1 (ru) Препарат, обладающий иммуностимулирующим действием
EP0686039A1 (fr) Procede d'amelioration de la reponse immunitaire aux vaccins oraux
RU2053781C1 (ru) Препарат из живых лактобактерий
GB2132481A (en) Pharmaceutical compositions containing human pepsin or pepsin-like enzymes
US20050119224A1 (en) Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for adjuvant treatment of perianal disease
Ebringer et al. Effect of trypacidin on Toxoplasma gondii in tissue culture and in mice